ARCHIVES

Division Directors Won’t Control Grants Budget, Upton Insists

This article is from The Cancer Letter archive.

Vol. 04 No. 08 | February 24, 1978

Download PDF Visit The Full Archive

Related Articles

Compendia Publishers Must Tell CMS How They Manage Conflicts Of Interest

November 13, 2009

Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials.

October 15, 2004

Cyclamate Committee Finds No Proof Of Carcinogenicity

January 23, 1976

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

May 31, 2013

Clanton Resigns From NCI.

January 12, 2007

Arizona Cancer Center Wins Core Grant Renewal

June 26, 2009